Cleared Traditional

K200264 - Exofin High Viscosity Topical Skin Adhesive (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K200264 · Chemence Medical, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
318d
Days
Class 2
Risk

K200264 is an FDA 510(k) clearance for the Exofin High Viscosity Topical Skin Adhesive. Classified as Tissue Adhesive For The Topical Approximation Of Skin (product code MPN), Class II - Special Controls.

Submitted by Chemence Medical, Inc. (Alpharetta, US). The FDA issued a Cleared decision on December 17, 2020 after a review of 318 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4010 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Chemence Medical, Inc. devices

Submission Details

510(k) Number K200264 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 03, 2020
Decision Date December 17, 2020
Days to Decision 318 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
204d slower than avg
Panel avg: 114d · This submission: 318d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MPN Tissue Adhesive For The Topical Approximation Of Skin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4010
Definition Docket Number: 2006p-0071 - May 5, 2008 - Reclassified From Class 3 Pma To Class 2 510(k).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - MPN Tissue Adhesive For The Topical Approximation Of Skin

All 35
Devices cleared under the same product code (MPN) and FDA review panel - the closest regulatory comparables to K200264.
BondEase 2 Topical Skin Adhesive
K243990 · Optmed, Inc. · Sep 2025
CUTIVA™ Topical Skin Adhesive (RM1700)
K250950 · Okapi Medical, LLC Dba Resivant Medical · Aug 2025
CUTIVA(TM) Topical Skin Adhesive (RM-1700)
K234114 · Okapi Medical, LLC Dba Resivant Medical · Aug 2024
CM005 Standard (CM005)
K233458 · Connexicon Medical , Ltd. · Jul 2024
Meriglu Topical Skin Adhesive
K230981 · M/s. Meril Endo Surgery Private Limited. · Mar 2024
Exofin Precision Pen
K212246 · Chemence Medical, Inc. · Sep 2021